Sage Journals: Discover world-class research

Abstract

Ultrasound is widely used as a screening tool in obstetrics with the aim of reducing maternal and foetal morbidity. However, to be effective it is recommended that scanning services follow standard protocols based on national guidelines and that scanning practice is audited to ensure consistency. Bradford has a multi-ethnic population with one of the highest rates of birth defects in the UK and it requires an effective foetal anomaly screening service. We implemented a rolling programme of audits of dating scans, foetal anomaly scans and growth scans carried out by sonographers in Bradford. All three categories of scan were audited using measurable parameters based on national guidelines. Following feedback and re-training to address issues identified, re-audits of dating and foetal anomaly scans were carried out. In both cases, sonographers being re-audited had a marked improvement in their practice. Analysis of foetal abnormality detection rates showed that as a department, we were reaching the nationally agreed detection rates for the Fetal Anomaly Screening Programme auditable conditions. Audit has been shown to be a useful and essential process in achieving consistent scanning practices and high quality images and measurements.

Keywords

Obstetric audit foetal anomaly screening programme foetal measurements

Get full access to this article

View all access options for this article.

References

Ultrasound Screening for Fetal Abnormalities. Report of the Royal College of Obstetricians and Gynaecologists working party. London: RCOG, 1997.

Ultrasound Screening – Supplement to Ultrasound Screening for Fetal Abnormalities. RCOG, London, 2000. See http://www.rcog.org.uk/womens-health/clinical-guidance/ultrasound-screening (last checked 17 February 2014).

NHS Fetal Anomaly Screening Programme 18+0 to 20+6 Weeks Fetal Anomaly Scan – National Standards and Guidance for England. NHS Fetal Anomaly Screening Programme, Exeter, UK, 2010. See http://fetalanomaly.screening.nhs.uk/standardsandpolicies (last checked 17 February 2014).

Green Top guidelines No 31-Investigation and management of small-for-gestation –Age Fetus. RCOG, London, 2000. See http://www.rcog.org.uk/womens-health/investigation-and-management-small-gestational-age-fetus-green-top-31 (last checked 18 February 2014).

Sheridan

Wright

Small

. Risk factors for congenital anomaly in a multi-ethnic birth cohort: an analysis of the Born in Bradford Study. Lancet 2013; 382: 1350–9.

A Guide to Getting the Most from the Ultrasound Equipment when Measuring Nuchal Translucency. NHS Fetal Anomaly Screening Programme, Exeter, UK, 2012. See http://fetalanomaly.screening.nhs.uk/leafletsforprofessionals (last checked 6 March 2014).

Measuring the NT and CRL as Part of the Combined Screening for Trisomy 21 in England Manual for Ultrasound Practitioners. FASP, Exeter, 2012. See http://www.fetalanomaly.screening.nhs.uk/getdata.php?id=11685 (last checked 18 February 2014).

Multiple Pregnancy: The Management of Twin and Triplet Pregnancies in the Antenatal Period. Clinical Guidance CG129. NICE September 2011. See http://www.nice.org.uk/CG129 (last checked 11 March 2014).

Placenta Praevia, Placenta Praevia Accreta and Vasa Praevia: Diagnosis and Management. Green-top Guideline No 27; 2011. London: Royal College of Obstetricians and Gynaecologists. See http://www.rcog.org.uk/womens-health/clinical-guidance/placenta-praevia-and-placenta-praevia-accreta-diagnosis-and-manageme (last checked 1 May 2011).

Obstetric audit: the Bradford way

Abstract

Keywords

Get full access to this article

References